Meet the team

Our team brings a rich background of pharmaceutical, biotechnology and CRO drug development expertise to companies we invest in.

Alek Safarian
Alek Safarian

CEO

Alek has a diverse background in drug development spanning more than thirty years. Trained as a pharmacist, he worked in regulatory affairs and clinical research roles for European and US-based multinational pharmaceutical companies in Australia, with responsibility across the Asia-Pacific. He subsequently founded Novotech, a Sydney-based contract research organisation working with hundreds of clinical stage biotech companies over a twenty-one year period. Alek holds a BPharm and an MBA from the University of Sydney.

Dr Graeme Martin
Dr Graeme Martin

CIO

Graeme has a forty-year background in Pharma and Biotech across Europe, USA and Japan. After his pharmacology studies, he held senior R&D roles in the UK and USA in multinational companies such as Roche, GSK and Wellcome Research Laboratories. Graeme was President and CEO of Takeda Ventures, the corporate venture arm of Takeda Pharmaceuticals, a global pharmaceutical company. He is a dealmaker with extensive experience in all aspects of venture capital investing, including exits. Graeme holds a BSc and a PhD in Pharmacology.

Lorna Collings
Lorna Collings

CFO

Lorna has more than twenty years of experience in private equity and venture capital with roles at EQT, Hermes GPE, Citco, Coller Capital, Ariadne Capital, Actis and BancBoston Capital. She holds a BA in Applied Physiology and is registered with the Chartered Institute of Management Accountants (ACMA).

Dr Robert Balfour
Dr Robert Balfour

Investment Director

Robert has a successful background in venture capital and Big Pharma, with companies such as GSK and Eli Lilly. He is a passionate startup entrepeneur with experience in university technology transfer. Robert holds a BSc in Physiology and a PhD in Neurophysiology.

Dr Sohaib Mir
Dr Sohaib Mir

Investment Director

Sohaib has a successful background in venture capital and healthcare investment banking with Perella Weinberg Partners. He practiced medicine at Addenbrooke’s Hospital in Cambridge. Sohaib holds a PhD in CNS Regeneration and an MPhil in Bioscience Enterprise.

Julia Jones
Julia Jones

Investment Manager

Julia has a thirty-year background in Pharma and CRO, with companies such as Johnson & Johnson, Iqvia and Novotech. She also has experience in clinical nursing and research.

Katie Sunnucks
Katie Sunnucks

Analyst

Katie has strong venture capital experience and held roles at Johnson & Johnson. She holds a BMedSc in Medical Science and an MPhil in Bioscience Enterprise.